NASDAQ:OLMA

Olema Pharmaceuticals Stock Forecast

etoro logo Buy OLMA
*Your capital is at risk
$12.05
+0.250 (+2.12%)
At Close: Aug 07, 2026

Should you buy OLMA stock?

Last updated:

Based on market data through , StockInvest.us rates Olema Pharmaceuticals Inc (OLMA) as Hold/Accumulate with a technical score of -0.80 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Hold signal since
  • Price since signal Up 2.47%
  • 3-month trend forecast Down 11.99%
  • Hold/Accumulate -0.80
AI Analysis AI Analysis of OLMA AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add OLMA to Watchlist?
Some Reasons Why To Add OLMA:
  • +159.7% price growth over the last year
  • Low bankruptcy risk (Altman Z-Score: 10.51)
  • Highly efficient cash conversion (100% FCF/OCF ratio)
PDF

Olema Pharmaceuticals Inc stock price ended at $12.05 on Friday, after gaining 2.12%
(Market data through Aug 07, 2026)

Hold candidate since Aug 04, 2026 Gain 2.47%

The Olema Pharmaceuticals Inc stock price gained 2.12% on the last trading day (Friday, 7th Aug 2026), rising from $11.80 to $12.05. During the last trading day the stock fluctuated 2.27% from a day low at $11.87 to a day high of $12.14. The price has been going up and down for this period, and there has been a 2.99% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 240 more shares were traded than the day before. In total, 748 thousand shares were bought and sold for approximately $9.02 million.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $12.13 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -11.99% during the next 3 months and, with a 90% probability hold a price between $7.24 and $10.68 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

OLMA Signals & Forecast

The Olema Pharmaceuticals Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $11.68 and $11.65. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, July 06, 2026, and so far it has fallen -5.64%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Olema Pharmaceuticals Inc stock

On the downside, the stock finds support just below today's level from accumulated volume at $11.39 and $10.69. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Olema Pharmaceuticals Inc finds support just below today's level at $11.39. If this is broken, then the next support from accumulated volume will be at $10.69 and $9.51.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.270 (2.27%) between high and low. For the last week, the stock has had daily average volatility of 5.31%.

Our recommended stop-loss: $11.54 (-4.27%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 24 days ago.)

Trading Expectations (OLMA) For The Upcoming Trading Day Of Monday 10th

For the upcoming trading day on Monday, 10th we expect Olema Pharmaceuticals Inc to open at $12.02, and during the day (based on 14 day Average True Range), to move between $11.72 and $12.38, which gives a possible trading interval of +/-$0.657 (+/-5.60%) up or down from last closing price. If Olema Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 5.60% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $12.08 (0.25%) than the support at $11.39 (5.48%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Olema Pharmaceuticals Inc stock A Buy?

Olema Pharmaceuticals Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: -0.796 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 10, 2026 - $12.02 ( 0.249%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

OLMA Performance

Trading levels for OLMA

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 12.29 1.99%
R2 12.19 1.14%
R1 12.12 0.607%
Price 12.05
S1 11.92 -1.10%
S2 11.85 -1.63%
S3 11.75 -2.49%

Accumulated Volume Support & Resistance Levels

Level Price
R3 13.97 15.93%
R2 12.51 3.82%
R1 12.08 0.249%
Price 12.05
S1 11.39 -5.48%
S2 10.69 -11.29%
S3 9.51 -21.08%

FAQ

What is the symbol for Olema Pharmaceuticals Inc Stock and on which exchange is it traded?
The symbol for Olema Pharmaceuticals Inc is OLMA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Olema Pharmaceuticals Inc Stock?
Based on market data through Aug 07, 2026, StockInvest.us rates Olema Pharmaceuticals Inc (OLMA) as Hold/Accumulate with a technical score of -0.80 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Hold signal began on Aug 04, 2026, the price has risen 2.47%. The current 3-month trend forecast projects a fall of 11.99%.

How to buy Olema Pharmaceuticals Inc Stock?
Olema Pharmaceuticals Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Olema Pharmaceuticals Inc Stock.

What's the current price of Olema Pharmaceuticals Inc Stock?
As of the end of day on the Aug 07, 2026, the price of an Olema Pharmaceuticals Inc (OLMA) share was $12.05.

What is the 52-week high and low for Olema Pharmaceuticals Inc Stock?
The 52-week high for Olema Pharmaceuticals Inc Stock is $36.26 and the 52-week low is $4.47.

What is the market capitalization of Olema Pharmaceuticals Inc Stock?
As of the Aug 07, 2026, the market capitalization of Olema Pharmaceuticals Inc is 1.053B.

When is the next earnings date for Olema Pharmaceuticals Inc?
The upcoming earnings date for Olema Pharmaceuticals Inc is Aug 10, 2026.
Click to get the best stock tips daily for free!
ABOUT OLEMA PHARMACEUTICALS INC
Olema Pharmaceuticals
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negativ...
GOLDEN STAR
Ticker Change Signal Date
MHO
$150.54
0.96% Aug 05
JEF
$55.71
1.63% Aug 04
FCX
$62.63
11.16% Jul 31
BIIB
$202.19
2.84% Jul 24
S
SW
$43.71
10.46% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE